Plague as HIV vaccine adjuvant
Individuals homozygous for a 32-basepair deletion mutation (null mutation) in CCR5, a chemokine receptor, are nearly immune to developing HIV infection. Recently based on molecular dating evidence it has been proposed that the bacterium Yersinia pestis, cause of plague, may have been the selective p...
Gespeichert in:
Veröffentlicht in: | Medical hypotheses 2000-06, Vol.54 (6), p.1003-1004 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Individuals homozygous for a 32-basepair deletion mutation (null mutation) in CCR5, a chemokine receptor, are nearly immune to developing HIV infection. Recently based on molecular dating evidence it has been proposed that the bacterium Yersinia pestis, cause of plague, may have been the selective pressure which selected for a high prevalence of the 32-basepair null mutation. An association of a robust chemokine response with HIV vaccine efficacy has recently been shown. I suggest that Y. pestis may be a useful adjuvant in an HIV vaccine protocol by stimulating a vigorous chemokine response. |
---|---|
ISSN: | 0306-9877 1532-2777 |
DOI: | 10.1054/mehy.1999.1017 |